The Epidermal Growth Factor Receptor (EGFR) is part of the broad group of receptor tyrosine kinases; according to The Cancer Genome Atlas (TCGA) data, alterations of EGFR gene are present in around 25% of gliomas: 54% of GBMs and 9% of lower grade gliomas [7]. Here, EGFR is linked to central nervous system cancer.